Amit Verma - Professor, Oncology, Developmental and Molecular Biology, Medicine - Albert Einstein College of Medicine, Montefiore Medical Center | LinkedIn
World Journal of Gastroenterology - Baishideng Publishing Group
Mantzaris Ioannis - Ιατροτεχνολογικά καρδιολογικά προϊόντα - Mantzaris A.E. | LinkedIn
PDF) Identification and Expansion of an Adaptive Natural Killer Cell Subset Present in Cord Blood
Ioannis Mantzaris - Fellow - Montefiore Medical Center | LinkedIn
Amit Verma - Professor, Oncology, Developmental and Molecular Biology, Medicine - Albert Einstein College of Medicine, Montefiore Medical Center | LinkedIn
Hematology-Oncology – Fellowship - Faculty Team - New York City – Montefiore Medical Center
Dr. Ioannis Mantzaris MD - Bronx, NY | CareDash
Cancer Care – Services and Treatments – Medical Oncology Team – New York, New York – Montefiore Einstein Center for Cancer Care
Flow cytometric analysis (Annexin V/PI method) of the toxic effect of... | Download Scientific Diagram
Yanhua Wang, M.D., Ph.D. | Faculty Directory | Albert Einstein College of Medicine
Ioannis Mantzaris, MD: Bronx, NY
Dr. Ioannis Mantzaris MD - Bronx, NY | CareDash
Meet the Hematologic Malignancy Team
Anthony P. Lam's research works | Stanford University, CA (SU) and other places
IOANNIS MANTZARIS M.D, NPI 1871865519 - Legal Medicine in Bronx, NY
Dr. Ioannis Mantzaris, MD, Hematology & Oncology Specialist - Bronx, NY | Sharecare
Meet the Hematologic Malignancy Team - Dr. Ioannis Mantzaris, MD
Davendra P. Sohal, MD, MPH
World Journal of Gastroenterology - Baishideng Publishing Group
Cancer Care – Services and Treatments – Medical Oncology Team – New York, New York – Montefiore Einstein Center for Cancer Care
Novel Drug Shows Promise Against Acute Myeloid Leukemia | Albert Einstein College of Medicine
Meet the Hematologic Malignancy Team
PDF) Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity
PDF) Trastuzumab plus Paclitaxel or Docetaxel in HER-2-Negative/HER-2 ECD-Positive Anthracycline- and Taxane-Refractory Advanced Breast Cancer
